Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis

Endocrine-Related Cancer

Volumn 21, Issue 3, 2014, Pages

  Ma, Wen Lung ^a,b   Lai, Hsueh Chou ^a   Yeh, Shuyuan ^b   Cai, Xiujun ^c   Chang, Chawnshang ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Androgen receptor (AR); Hepatocellular carcinoma (HCC)

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; ASC J 9; CARCINOGEN; SORAFENIB; UNCLASSIFIED DRUG;

BILE DUCT CARCINOMA; CANCER PATIENT; CANCER STAGING; CELL MIGRATION; CELL RENEWAL; EARLY CANCER; FATTY LIVER; HEPATITIS; HEPATITIS B VIRUS; HUMAN; KNOCKOUT MOUSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER REGENERATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; FATTY LIVER; HEPATITIS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICE; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84899861735     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0283     Document Type: Review

References (158)

1. Alvaro D, Barbaro B, Franchitto A, Onori P, Glaser SS, Alpini G, Francis H, Marucci L, Sterpetti P, Ginanni-Corradini S et al. 2006 Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. American Journal of Pathology 169 877-888. (doi:10.2353/ajpath.2006.050464) (Pubitemid 44411954)
2. Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ & Goldberg D 2011 Hepatitis B prevention, diagnosis, treatment and care: a review. Occupational Medicine 61 531-540. (doi:10.1093/occmed/kqr136)
3. Baig S 2009 Gender disparity in infections of hepatitis B virus. Journal of the College of Physicians and Surgeons Pakistan 19 598-600.
4. Bluemn EG & Nelson PS 2012 The androgen/androgen receptor axis in prostate cancer. Current Opinion in Oncology 24 251-257. (doi:10.1097/CCO. 0b013e32835105b3)
5. Bradbury MW 2006 Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. American Journal of Physiology. Gastrointestinal and Liver Physiology 290 G194-G198. (doi:10.1152/ajpgi.00413. 2005)
6. Butterfield LH 2004 Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127S232-S241. (doi:10.1053/j.gastro.2004.09.038)
7. Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM & Fan ST 2011 Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Archives of Surgery 146 675-681. (doi:10.1001/archsurg.2011.125)
8. Chang CS, Kokontis J & Liao ST 1988 Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240 324-326. (doi:10.1126/science.3353726)
9. Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J & Lee SD 1996 Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 77 635-639. (doi:10.1002/(SICI)1097-0142(19960215)77: 4〈635::AID-CNCR8〉.0.CO;2-F)
10. Chen Y, Xiang LX, Shao JZ, Pan RL, Wang YX, Dong XJ & Zhang GR 2010 Recruitment of endogenous bone marrow mesenchymal stem cells towards injured liver. Journal of Cellular and Molecular Medicine 14 1494-1508. (doi:10.1111/j.1582-4934.2009.00912.x)
11. Chen T, Song D, Min Z, Wang X, Gu Y, Wei B, Yao J, Chen K, Jiang Z, Xie H et al. 2012 Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma. Journal of Translational Medicine 10 14. (doi:10.1186/1479-5876-10-14)
12. Chiu CM, Yeh SH, Chen PJ, Kuo TJ, Chang CJ, Chen PJ, YangWJ & Chen DS 2007 Hepatitis B virus X protein enhances androgen receptorresponsive gene expression depending on androgen level. PNAS 104 2571-2578. (doi:10.1073/pnas. 0609498104)
13. Chow JD, Jones ME, Prelle K, Simpson ER & Boon WC 2011 A selective estrogen receptor a agonist ameliorates hepatic steatosis in the male aromatase knockout mouse. Journal of Endocrinology 210 323-334. (doi:10.1530/JOE-10-0462)
14. Cicero AF, Tartagni E & Ertek S 2012 Metformin and its clinical use: new insights for an old drug in clinical practice. Archives of Medical Science 8 907-917. (doi:10.5114/aoms.2012.31622)
15. Claessens F, Verrijdt G, Schoenmakers E, Haelens A, Peeters B, Verhoeven G & Rombauts W 2001 Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. Journal of Steroid Biochemistry and Molecular Biology 76 23-30. (doi:10.1016/S0960-0760(00)00154-0)
16. Cornell RP, Liljequist BL & Bartizal KF 1990 Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice. Hepatology 11 916-922. (doi:10.1002/hep. 1840110603) (Pubitemid 20221025)
17. Cressman DE, Greenbaum LE, Haber BA & Taub R 1994 Rapid activation of post-hepatectomy factor/nuclear factor k B in hepatocytes, a primary response in the regenerating liver. Journal of Biological Chemistry 269 30429-30435. (Pubitemid 24376521)
18. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V & Taub R 1996 Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 1379-1383. (doi:10.1126/science.274. 5291.1379) (Pubitemid 26391463)
19. DeLoia JA, Burk RD & Gearhart JD 1989 Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice. Journal of Virology 63 4069-4073. (Pubitemid 19205488)
20. DimaA, Marinescu AG&DimaAC 2012 Non-alcoholic fatty liver disease and the statins treatment. Romanian Journal of Internal Medicine 50 19-25.
21. Di Maio M, Daniele B, Pignata S, Gallo C, De Maio E, Morabito A, Piccirillo MC & Perrone F 2008 Is human hepatocellular carcinoma a hormoneresponsive tumor? World Journal of Gastroenterology 14 1682-1689. (doi:10.3748/wjg.14.1682) (Pubitemid 351493374)
22. Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C & Poynard T 2004 Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 40 1426-1433. (doi:10.1002/hep.20463) (Pubitemid 39657018)
23. DoumbaPP, Nikolopoulou M, Gomatos IP, KonstadoulakisMM&Koskinas J 2013 Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions. BMC Gastroenterology 13 17. (doi:10.1186/1471-230X-13-17)
24. El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S & Wahdan M 2012 Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Research 8 972-981. (doi:10.1007/s12015-011- 9322-y)
25. EvenC,LaunoyG,Collet T,DuvalO,PiquetMA,RougereauA,Verwaerde JC& Dao T 1997 Epidemiology of hepatocellular carcinoma in the Department of Calvados. Gastroenterologie Clinique et Biologique 21 450-458. (Pubitemid 27323640)
26. Fang B, Shi M, Liao L, Yang S, Liu Y & Zhao RC 2004 Systemic infusion of FLK1(C) mesenchymal stem cells ameliorate carbon tetrachlorideinduced liver fibrosis in mice. Transplantation 78 83-88. (doi:10.1097/01.TP.0000128326.95294. 14)
27. Farazi PA & DePinho RA 2006 The genetic and environmental basis of hepatocellular carcinoma. Discovery Medicine 6 182-186.
28. Fawzy IO, Negm M, Ahmed R, Esmat G, Hamdi N & Abdelaziz AI 2012 Tamoxifen alleviates hepatitis C virus-induced inhibition of both tolllike receptor 7 and JAK-STAT signalling pathways in PBMCs of infected Egyptian females. Journal of Viral Hepatitis 19 854-861. (doi:10.1111/j.1365-2893.2012. 01612.x)
29. Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, Zhao GJ, Ng SS, Lin MC, Yu J et al. 2011 Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis. Journal of Clinical Investigation 121 3159-3175. (doi:10.1172/JCI45967)
30. Forbes A, Wilkinson ML, IqbalMJ, Johnson PJ &Williams R 1987 Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5α-dihydrotestosterone. European Journal of Cancer & Clinical Oncology 23 1659-1664. (doi:10.1016/0277-5379(87)90446-9) (Pubitemid 18044644)
31. Furusyo N, Ogawa E, Sudoh M, Murata M, Ihara T, Hayashi T, Ikezaki H, Hiramine S, Mukae H, Toyoda K et al. 2012 Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial. Journal of Hepatology 57 1186-1192. (doi:10.1016/j.jhep.2012. 08.003)
32. Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A et al. 2011 Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Molecular Pharmaceutics 8 1538-1548. (doi:10.1021/mp200137c)
33. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N & Montalto G 2006 Sex hormones and risk of liver tumor. Annals of the New York Academy of Sciences 1089 228-236. (doi:10.1196/annals.1386.044) (Pubitemid 47092098)
34. Gluud C 1988 Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men. Danish Medical Bulletin 35 564-575.
35. Gluud C, Christoffersen P, Eriksen J, Wantzin P & Knudsen BB 1987 No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis. American Journal of Gastroenterology 82 660-664. (Pubitemid 17095828)
36. Gong L, Li YH, Su Q, Chu X & Zhang W 2010 Clonality of nodular lesions in liver cirrhosis and chromosomal abnormalities in monoclonal nodules of altered hepatocytes. Histopathology 56 589-599. (doi:10.1111/j.1365-2559. 2010.03523.x)
37. Green GR 1977 Mechanism of hypogonadism in cirrhotic males. Gut 18 843-853. (doi:10.1136/gut.18.10.843)
38. Guo CL, Yang HC, Yang XH, Cheng W, Dong TX, Zhu WJ, Xu Z & Zhao L 2013 Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma. Asian Pacific Journal of Cancer Prevention 13 5913-5917.
39. Guy J & Yee HF Jr 2009 Health disparities in liver disease: time to take notice and take action. Hepatology 50 309-313. (doi:10.1002/hep. 22942)
40. Haider A, Gooren LJ, Padungtod P & Saad F 2010 Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Experimental and Clinical Endocrinology & Diabetes 118 167-171. (doi:10.1055/s-0029- 1202774)
41. Hashimoto F, Davis RL & Egli D 1994 Hepatitis following treatments with famotidine and then cimetidine. Annals of Pharmacotherapy 28 37-39. (Pubitemid 24042481)
42. Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y et al. 2007 Primary liver cancers with nonalcoholic steatohepatitis. European Journal of Gastroenterology & Hepatology 19 827-834. (doi:10.1097/MEG.0b013e3282748ef2) (Pubitemid 47415140)
43. Hépatocellulaire. GdEedTdC 2004 Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen. Hepatology 40 1361-1369. (doi:10.1002/hep.20474)
44. HeronM, Hoyert DL, Murphy SL, Xu J, Kochanek KD & Tejada-Vera B 2009 Deaths: final data for 2006. National Vital Statistics Report 57 1-134.
45. Hoshino-Yoshino A, Kato M, Nakano K, Ishigai M, Kudo T & Ito K 2011 Bridging from preclinical to clinical studies for tyrosine kinase inhibitors based on pharmacokinetics/pharmacodynamics and toxicokinetics/toxicodynamics. Drug Metabolism and Pharmacokinetics 26 612-620. (doi:10.2133/dmpk.DMPK-11-RG- 043)
46. Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, Iloeje UH & Chen CJ 2011 Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. Journal of Clinical Oncology 29 3643-3650. (doi:10.1200/JCO.2011.36.2335)
47. Huang CK, Lee SO, Lai KP, Ma WL, Lin TH, TsaiMY, Luo J & Chang C 2013 Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology 57 1550-1563. (doi:10.1002/hep.26135)
48. Iloeje UH, Yang HI & Chen CJ 2012 Natural history of chronic hepatitis B: what exactly has REVEAL revealed? Liver International 32 1333-1341. (doi:10.1111/j.1478-3231.2012.02805.x)
49. Jacqueson A, Thevenin M, Warnet JM, Claude JR & Truhaut R 1978 Comparative study of the protective effect of an anabolic steroid. The 19-nortestosterone-phenylpropionate (19 NTPP), on liver steatosis induced by Amanita phalloides and white phosphorus in rats. Archives of Toxicology. Supplement 1 193-196. (Pubitemid 8347079)
50. Jemal A, Bray F, Center MM, Ferlay J, Ward E & Forman D 2011 Global cancer statistics. CA: A Cancer Journal for Clinicians 61 69-90. (doi:10.3322/caac.20107)
51. Jilma B, Eichler HG, Koppl C, Weber B, Pidlich JP, Ferenci P & Muller C 1998 Effects of testosterone suppression on serum levels of hepatitis B surface antigen and HBV-DNA in men. Liver 18 162-165. (doi:10.1111/j.1600-0676. 1998.tb00144.x) (Pubitemid 28368065)
52. JonesH, SprungVS, PughCJ, DaousiC, IrwinA, Aziz N, AdamsVL, Thomas EL, Bell JD, Kemp GJ et al. 2012 Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism 97 3709-3716. (doi:10.1210/jc.2012-1382)
53. Ju MJ, Qiu SJ, Gao Q, Fan J, Cai MY, Li YW & Tang ZY 2009 Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma. Cancer Science 100 1267-1274. (doi:10.1111/j.1349- 7006.2009.01182.x)
54. Jung ES, Kim JH, Yoon EL, Lee HJ, Lee SJ, Suh SJ, Lee BJ, Seo YS, Yim HJ, Seo TS et al. 2013 Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Journal of Hepatology 58 1181-1187. (doi:10.1016/j.jhep.2013. 01.039)
55. Kalra M, Mayes J, Assefa S, Kaul AK & Kaul R 2008 Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World Journal of Gastroenterology 14 5945-5961. (doi:10.3748/wjg.14.5945)
56. Kanda T, Steele R, Ray R & Ray RB 2008 Hepatitis C virus core protein augments androgen receptor-mediated signaling. Journal of Virology 82 11066-11072. (doi:10.1128/JVI.01300-08)
57. Kemp CJ & Drinkwater NR 1989 Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice. Cancer Research 49 5044-5047. (Pubitemid 19239340)
58. Kew MC, Kirschner MA, Abrahams GE & Katz M 1977 Mechanism of feminization in primary liver cancer. New England Journal of Medicine 296 1084-1088. (doi:10.1056/NEJM197705122961903) (Pubitemid 8091585)
59. Kley HK 1979 Plasma-estrogens and liver cirrhosis. Zeitschrift für Gastroenterologie 17 406-412. (Pubitemid 9232057)
60. Kuper H, Lagiou P,Mucci LA, Tamimi R, Benetou V & Trichopoulos D 2001a Risk factors for cholangiocarcinoma in a low risk Caucasian population. Sozial-und Praventivmedizin 46 182-185. (doi:10.1007/BF01324254) (Pubitemid 32747277)
61. Kuper H, Mantzoros C, Lagiou P, Tzonou A, Tamimi R, Mucci L, Benetou V, Spanos E, Stuver SO & Trichopoulos D 2001b Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men. Oncology 60 355-360. (doi:10.1159/000058532) (Pubitemid 32623451)
62. Kwon H & Lok AS 2011 Does antiviral therapy prevent hepatocellular carcinoma? Antiviral Therapy 16 787-795. (doi:10.3851/IMP1895)
63. Lai KP, Yamashita S, Huang CK, Yeh S & Chang C 2012 Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. EMBO Molecular Medicine 4 791-807. (doi:10.1002/emmm.201101140)
64. Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S & Chang C 2013 New therapeutic approach to suppress castrationresistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. American Journal of Pathology 182 460-473. (doi:10.1016/j. ajpath.2012.10.029)
65. Lampropoulou-Karatzas C, Goritsas P & Makri MG 1993 Low serum testosterone: a special feature of hepatocellular carcinoma. European Journal of Medicine 2 23-27. (Pubitemid 23042548)
66. Lee MH, Yang HI, Jen CL, Lu SN, Yeh SH, Liu CJ, You SL, Sun CA, Wang LY, Chen WJ et al. 2011 Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2. Gut 60 688-694. (doi:10.1136/gut.2010.220889)
67. Li Z, Tuteja G, Schug J & Kaestner KH 2012 Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell 148 72-83. (doi:10.1016/j. cell.2011.11.026)
68. Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES & Tan SB 2012 Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. British Journal of Surgery 99 1622-1629. (doi:10.1002/bjs.8915)
69. Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD & Chang C 2005 Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54 1717-1725. (doi:10.2337/diabetes.54.6.1717) (Pubitemid 40770762)
70. Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD et al. 2008 Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47 1924-1935. (doi:10.1002/hep.22252) (Pubitemid 351945560)
71. Liossi AK, Aroni KG, Kyrkou KA, Kittas C & Markaki SP 1988 Immunohistochemical study of sex steroid hormones in primary liver cancer. Cancer Detection and Prevention 13 195-201.
72. Littmann KP, Winter G & Gerdes H 1973 Gerdes Aktivitätsä nderungen testosteroninaktivierender Enzyme in menschlichem Lebergewebe bei Cholostase und Lebercirrhose. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79 1258-1261.
73. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A et al. 2008 Sorafenib in advanced hepatocellular carcinoma. New England Journal of Medicine 359 378-390. (doi:10.1056/NEJMoa0708857)
74. Lund J, Zaphiropoulos PG, Mode A, Warner M & Gustafsson JA 1991 Hormonal regulation of cytochrome P-450 gene expression. Advances in Pharmacology 22 325-354.
75. Ma WL, Hsu CL, Wu MH, Wu CT,Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S & Chang C 2008 Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology 135 947-955. 955 e941-945. (doi:10.1053/j.gastro.2008.05.046)
76. Ma W, Jeng L, Yeh C & Chang C 2012a Androgen and androgen receptor signals jamming monocyte/macrophage functions in premalignant phase of livers. Biomedicine 2 155-159. (doi:10.1016/j.biomed.2012.09.001)
77. Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S & Chang C 2012b Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology 56 176-185. (doi:10.1002/hep.25644)
78. Magyar Z, Bekesi G, Racz K, Feher J, Schaff Z, Lengyel G, Blazovics A, Illyes G, Szombath D,Hrabak A et al. 2011 Increased total scavenger capacity and decreased liver fat content in rats fed dehydroepiandrosterone and its sulphate on a high-fat diet. Gerontology 57 343-349. (doi:10.1159/000321385)
79. Maheshwari A & Thuluvath PJ 2011 Endocrine diseases and the liver. Clinics in Liver Disease 15 55-67. (doi:10.1016/j.cld.2010.09.008)
80. Mancino A, MancinoMG, Glaser SS, Alpini G, Bolognese A, Izzo L, Francis H, Onori P, Franchitto A, Ginanni-Corradini S et al. 2009 Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor. Digestive and Liver Disease 41 156-163. (doi:10.1016/j.dld.2008.02.015)
81. Manso G, Thole Z, Salgueiro E, Revuelta P & Hidalgo A 2006 Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiology and Drug Safety 15 253-259. (doi:10.1002/pds.1168)
82. Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, Gore RM, Hall C, Nowak J, Roy H et al. 2012a Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part I: diagnosis-clinical staging and pathology. Journal of Surgical Oncology 106 332-338. (doi:10.1002/jso.23028)
83. Marsh Rde W, Alonzo M, Bajaj S, Baker M, Elton E, Farrell TA, Gore RM, Hall C, Nowak J, Roy H et al. 2012b Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. Journal of Surgical Oncology 106 339-345. (doi:10.1002/jso.23027)
84. Matsuzaki Y, Nagai D, Ichimura E, Goda R, Tomura A, DoiM& Nishikawa K 2006 Metabolismand hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice. Journal of Gastroenterology 41 231-239. (doi:10.1007/s00535-005-1749-y)
85. Michalopoulos GK & DeFrances MC 1997 Liver regeneration. Science 276 60-66. (doi:10.1126/science.276.5309.60)
86. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY et al. 2007 Promotion of bladder cancer development and progression by androgen receptor signals. Journal of the National Cancer Institute 99 558-568. (doi:10.1093/jnci/djk113) (Pubitemid 47078733)
87. Mode A, Tollet P, Strom A, Legraverend C, Liddle C & Gustafsson JA 1992 Growth hormone regulation of hepatic cytochrome P450 expression in the rat. Advances in Enzyme Regulation 32 255-263. (doi:10.1016/0065-2571(92)90021-Q)
88. Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, Fukuhara T, Uchiyama H, Ikegami T, Yoshizumi T et al. 2013 Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. Journal of Hepatology 58 58-64. (doi:10.1016/j.jhep.2012.08.017)
89. Murakami Y, Fukasawa M, Kaneko Y, Suzuki T, Wakita T & Fukazawa H 2013 Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. Microbes and Infection 15 45-55. (doi:10.1016/j.micinf.2012.10.003)
90. Murray M, Cantrill E, Mehta I & Farrell GC 1992 Impaired expression of microsomal cytochrome P450 2C11 in choline-deficient rat liver during the development of cirrhosis. Journal of Pharmacological and Experimental Therapeutics 261 373-380.
91. Nagasue N, Yu L, Yukaya H, Kohno H & Nakamura T 1995 Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. British Journal of Surgery 82 542-547. (doi:10.1002/bjs.1800820435)
92. Nakatani T, Roy G, Fujimoto N, Asahara T & Ito A 2001 Sex hormone dependency of diethylnitrosamine-induced liver tumors in mice and chemoprevention by leuprorelin. Japanese Journal of Cancer Research 92 249-256. (doi:10.1111/j.1349-7006.2001.tb01089.x) (Pubitemid 32288286)
93. Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM & Karin M 2007 Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317 121-124. (doi:10.1126/science.1140485) (Pubitemid 47056470)
94. Nieschlag E, Cuppers HJ & Wickings EJ 1977 Influence of sex, testicular development and liver function on the bioavailability of oral testosterone. European Journal of Clinical Investigation 7 145-147. (doi:10.1111/j.1365-2362.1977.tb01588.x) (Pubitemid 8288193)
95. Oshima H 1968 Androgens. Horumon to Rinsho 16 863-872.
96. Peng CY, Chien RN & Liaw YF 2012 Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. Journal of Hepatology 57 442-450. (doi:10.1016/j.jhep.2012.02.033)
97. Rambaldi A & Gluud C 2006 Anabolic-androgenic steroids for alcoholic liver disease. Cochrane Database of Systematic Reviews CD003045.
98. Rinaldi C, Lesmana A & LA Lesmana 2011 The role of liver biopsy in the non-invasive methods era and liver stiffness measurement using transient elastography. In Liver Biopsy, ch 1. Ed H Takahashi. Rijeka, Croatia: InTech. (doi:10.5772/19561)
99. Rogers AB, Theve EJ, Feng Y, Fry RC, Taghizadeh K, Clapp KM, Boussahmain C, Cormier KS & Fox JG 2007 Hepatocellular carcinoma associated with liver-gender disruption in male mice. Cancer Research 67 11536-11546. (doi:10.1158/0008-5472.CAN-07-1479)
100. Rossi L, Leveri M, Gritti C, De Silvestri A, Zavaglia C, Sonzogni L, Silvestri L, Civardi E, Mondelli MU & Silini EM 2003 Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. Journal of Hepatology 39 564-570. (doi:10.1016/S0168- 8278(03)00355-6) (Pubitemid 37204657)
101. Ruggieri A, Barbati C & Malorni W 2010 Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity. International Journal of Cancer 127 499-504. (doi:10.1002/ijc.25298)
102. Saint-Aubert B, Vic P, Brissac C, Bories P, Humeau C, Joyeux H & Solassol C 1980 Hepatic regeneration in the rat after subtotal (90%) hepatectomy treated with testosterone. Comptes rendus de l'Académie des Sciences D. Sciences Naturelles 291 653-655. (Pubitemid 11163776)
103. Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G & Falagas ME 2010 Chronic bacterial and parasitic infections and cancer: a review. Journal of Infection in Developing Countries 4 267-281.
104. Sato K & Mori M 2011 Evolving molecular mechanism-based strategies for control of hepatocellular carcinoma. Current Medicinal Chemistry 18 4375-4388. (doi:10.2174/092986711797200462)
105. Schiff ER, Sorrell MF & Maddrey WC 2003 Schiff's Disease of the Liver. Philadelphia, PA: Lippincott William & Wilkins.
106. Schwingel PA, CotrimHP, Salles BR, Almeida CE, dos Santos CR Jr, Nachef B, Andrade AR & Zoppi CC 2011a Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. Liver International 31 348-353. (doi:10.1111/j.1478-3231.2010.02346.x)
107. Schwingel PA, Zoppi CC & Cotrim HP 2011b Increased liver steatosis in anabolic-androgenic steroid users: more evidence towards toxicantassociated fatty liver disease development. Liver International 31 1240-1241. (doi:10.1111/j.1478-3231.2011.02552.x)
108. Seki S, Habu Y, Kawamura T, Takeda K, Dobashi H, Ohkawa T & Hiraide H 2000 The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 AgCT cells in T helper 1 immune responses. Immunological Reviews 174 35-46. (doi:10.1034/j.1600-0528. 2002.017404.x) (Pubitemid 30201377)
109. Seruga B & Tannock IF 2011 Chemotherapy-based treatment for castrationresistant prostate cancer. Journal of Clinical Oncology 29 3686-3694. (doi:10.1200/JCO.2010.34.3996)
110. Sherwood DR, Butler JA, Kramer JM & Sternberg PW 2005 FOS-1 promotes basement-membrane removal during anchor-cell invasion in C. elegans. Cell 121 951-962. (doi:10.1016/j.cell.2005.03.031)
111. Shimizu Y 2012 T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection. World Journal of Gastroenterology 18 2443-2451. (doi:10.3748/wjg.v18.i20.2443)
112. Shin HS, Kim SU, Park JY, Kim do Y, Han KH, Chon CY, Baatarkhuu O & Ahn SH 2012 Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 27 1528-1534. (doi:10.1111/j.1440-1746.2012. 07145.x)
113. Shirabe K, Mano Y, Muto J,Matono R, Motomura T, Toshima T, Takeishi K, Uchiyama H, Yoshizumi T, Taketomi A et al. 2012 Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surgery Today 42 1-7. (doi:10.1007/s00595-011-0058-8)
114. Sorensen HT, Thulstrup AM, Mellemkjar L, Jepsen P, Christensen E, Olsen JH & Vilstrup H 2003 Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark. Journal of Clinical Epidemiology 56 88-93. (doi:10.1016/S0895-4356(02)00531-0) (Pubitemid 36183320)
115. Sparks JD & Sparks CE 2008 Overindulgence and metabolic syndrome: is FoxO1 a missing link? Journal of Clinical Investigation 118 2012-2015. (Pubitemid 351872319)
116. Swift LL, Farkas MH, Major AS, Valyi-Nagy K, Linton MF & Fazio S 2001 A recycling pathway for resecretion of internalized apolipoprotein E in liver cells. Journal of Biological Chemistry 276 22965-22970. (doi:10.1074/jbc. M100172200)
117. Takahashi Y, Soejima Y & Fukusato T 2012 Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World Journal of Gastroenterology 18 2300-2308. (doi:10.3748/wjg.v18.i19.2300)
118. Takami T, Terai S & Sakaida I 2012 Advanced therapies using autologous bone marrow cells for chronic liver disease. Discovery Medicine 14 7-12.
119. Tamori A & Kawada N 2012 Interferon. Nippon Rinsho 70 620-624.
120. Tanaka K, Sakai H, Hashizume M & Hirohata T 2000 Serum testosterone: estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Research 60 5106-5110.
121. Tavian D, De Petro G, Pitozzi A, Portolani N, Giulini SM & Barlati S 2002 Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma. Histology and Histopathology 17 1113-1119.
122. Tejura S, Rodgers GR, Dunion MH, Parsons MA, Underwood JC & Ingleton PM 1989 Sex-steroid receptors in the diethylnitrosamine model of hepatocarcinogenesis: modifications by gonadal ablation and steroid replacement therapy. Journal of Molecular Endocrinology 3 229-237. (doi:10.1677/jme.0. 0030229) (Pubitemid 19267698)
123. Theve EJ, Feng Y, Taghizadeh K, Cormier KS, Bell DR, Fox JG & Rogers AB 2008 Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus. Infection and Immunity 76 4071-4078. (doi:10.1128/IAI.00401-08)
124. Thole Z,Manso G, Salgueiro E, Revuelta P & Hidalgo A 2004 Hepatotoxicity induced by antiandrogens: a review of the literature. Urologia Internationalis 73 289-295. (doi:10.1159/000081585) (Pubitemid 39664297)
125. Tian Y, Kuo CF, Chen WL & Ou JH 2012 Enhancement of hepatitis B virus replication by androgen and its receptor in mice. Journal of Virology 86 1904-1910. (doi:10.1128/JVI.06707-11)
126. Valero V III, Cosgrove D, Herman JM & Pawlik TM 2012 Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Review of Gastroenterology & Hepatology 6 481-495. (doi:10.1586/egh.12.20)
127. Vanneaux V, Farge-Bancel D, Lecourt S, Baraut J, Cras A, Jean-Louis F, Brun C, Verrecchia F, Larghero J & Michel L 2013 Expression of transforming growth factor b receptor II in mesenchymal stem cells from systemic sclerosis patients. BMJ Open 3. (doi:10.1136/bmjopen-2012-001890)
128. Vassilatou E, Lafoyianni S, Vryonidou A, Ioannidis D, Kosma L, Katsoulis K, Papavassiliou E & Tzavara I 2010 Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Human Reproduction 25 212-220. (doi:10.1093/humrep/dep380)
129. Vizoso FJ, Rodriguez M, Altadill A, Gonzalez-Dieguez ML, Linares A, Gonzalez LO, Junquera S, Fresno-Forcelledo F, Corte MD & Rodrigo L 2007 Liver expression of steroid hormones and Apolipoprotein D receptors in hepatocellular carcinoma. World Journal of Gastroenterology 13 3221-3227. (Pubitemid 47064585)
130. Wang AG, Lee KY, Kim SY, Choi JY, Lee KH, Kim WH, Wang HJ, Kim JM, Park MG, Yeom YI et al. 2006 The expression of estrogen receptors in hepatocellular carcinoma in Korean patients. Yonsei Medical Journal 47 811-816. (doi:10.3349/ymj.2006.47.6.811) (Pubitemid 46029639)
131. Wang J, Su B, Ding Z, Du X & Wang B 2008 Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. Biochemical and Biophysical Research Communications 372 491-496. (doi:10.1016/j.bbrc.2008.04.191)
132. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS & Chen PJ 2009 Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 50 1392-1402. (doi:10.1002/hep.23163)
133. Waxman DJ & O'Connor C 2006 Growth hormone regulation of sex-dependent liver gene expression. Molecular Endocrinology 20 2613-2629. (doi:10.1210/me.2006-0007) (Pubitemid 44833525)
134. Weickert MO, Hodges P, Tan BK & Randeva HS 2012 Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin. Minerva Endocrinologica 37 25-40.
135. Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM & Terrault NA 2005 Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41 372-379. (doi:10.1002/hep.20554) (Pubitemid 40165382)
136. White DL, Kanwal F & El-Serag HB 2012a Association between
137. White DL, Tavakoli-Tabasi S, Kuzniarek J, Pascua R, Ramsey DJ & El-Serag HB 2012b Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology 55 759-768. (doi:10.1002/hep.24618)
138. Wild S, Roglic G, Green A, Sicree R & King H 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 1047-1053. (doi:10.2337/diacare.27.5.1047) (Pubitemid 38579764)
139. Williams R 2006 Global challenges in liver disease. Hepatology 44 521-526. (doi:10.1002/hep.21347) (Pubitemid 44433707)
140. Wright TL & Lau JY 1993 Clinical aspects of hepatitis B virus infection. Lancet 342 1340-1344. (doi:10.1016/0140-6736(93)92250-W) (Pubitemid 23345184)
141. Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S & Chang C 2010 Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Translational Medicine 2 32ra35.
142. Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS et al. 2007 ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nature Medicine 13 348-353. (doi:10.1038/nm1547) (Pubitemid 46376683)
143. Yang X, Zhang YK, Esterly N, Klaassen CD & Wan YJ 2009 Gender disparity of hepatic lipid homoeostasis regulated by the circadian clock. Journal of Biochemistry 145 609-623. (doi:10.1093/jb/mvp018)
144. Yang F, Yin Y,Wang F, Zhang L, Wang Y & Sun S 2010 An altered pattern of liver apolipoprotein A-I isoforms is implicated in male chronic hepatitis B progression. Journal of Proteome Research 9 134-143. (doi:10.1021/pr900593r)
145. Yau T, Chan P, Epstein R & Poon RT 2009 Management of advanced hepatocellular carcinoma in the era of targeted therapy. Liver International 29 10-17. (doi:10.1111/j.1478-3231.2008.01916.x)
146. Yeh SH & Chen PJ 2010 Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78 (Suppl 1) 172-179. (doi:10.1159/ 000315247)
147. Yeh S, Chang HC, Miyamoto H, Takatera H, Rahman M, Kang HY, Thin TH, Lin HK & Chang C 1999 Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators. Keio Journal of Medicine 48 87-92. (doi:10.2302/kjm.48.87)
148. Yoon G, Kim JY, Choi YK, Won YS & Lim IK 2006 Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. Journal of Cellular Biochemistry 97 393-411. (doi:10.1002/jcb.20638) (Pubitemid 43168392)
149. Yoshitsugu M & Ihori M 1997 Endocrine disturbances in liver cirrhosisfocused on sex hormones. Nippon Rinsho 55 3002-3006.
150. Yu L, Kubota H, Imai K, Yamaguchi M & Nagasue N 1997 Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1). Liver 17 35-40. (doi:10.1111/j.1600-0676.1997.tb00776.x) (Pubitemid 27092780)
151. Yu MW, Cheng SW, Lin MW, Yang SY, Liaw YF, Chang HC, Hsiao TJ, Lin SM, Lee SD & Chen PJ 2000 Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. Journal of the National Cancer Institute 92 2023-2028. (doi:10.1093/jnci/92.24. 2023)
152. Yu MW, Yang YC, Yang SY, Cheng SW, Liaw YF, Lin SM & Chen CJ 2001 Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. Journal of National Cancer Institute 93 1644-1651. (doi:10.1093/jnci/93.21.1644)
153. Yuan JM, Ross RK, Stanczyk FZ, Govindarajan S, Gao YT, Henderson BE & Yu MC 1995 A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. International Journal of Cancer 63 491-493. (doi:10.1002/ijc.2910630405)
154. Yurci A, YucesoyM, Unluhizarci K, Torun E, Gursoy S, Baskol M, Guven K & Ozbakir O 2011 Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 35 845-854. (doi:10.1016/j.clinre.2011.09.005)
155. Zhang Y, Chen WL, Ma WL, Chang C & Ou JH 2007 Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363 454-461. (doi:10.1016/j.virol.2007.01.040)
156. Zhang H, Liu Y, Wang L, Li Z, Wu J, Rahman N, Guo Y, Li D, Li N, Huhtaniemi I et al. 2013 Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. Journal of Lipid Research 54 345-357. (doi:10.1194/jlr.M028969)
157. Zheng Y, Chen WL, Ma WL, Chang C & Ou JH 2007 Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology 363 454-461. (doi:10.1016/j.virol.2007.01.040)
158. Zhu R, Zhang JS, Zhu YZ, Fan J, Mao Y, Chen Q & Zhu HG 2011 HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter. Histology and Histopathology 26 23-35.